Motivational Interviewing With Diabetes Patients
Effects of Motivational Interviewing Intervention on Self- Management and HbA1c in Type 2 Diabetes Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
This study was conducted in a quasi-experimental research design with a pretest-posttest control group to determine the effect of motivational interviewing on self-management and HbA1c in patients with type 2 diabetes. The sample of the study consisted of 25 experimental and 26 controls, who applied to an outpatient clinic in a training and research hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Feb 2017
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2017
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 12, 2022
CompletedJanuary 12, 2022
December 1, 2021
3 months
December 8, 2021
December 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the pretest-posttest Diabetes Self-management Instrument-35 scores
The instrument is comprised of 35 questions covering the period from the previous three months to determine the frequency of the implementation of the self-management skills of the patients. The total score for the Instrument ranged from 35 to 140. A higher score showed that self-management activities were implemented on a more regular basis. Interventions consisted of four sessions of 30-60 (mean 45 min) min each. The sessions were structured according to the Behavior Change Stage Identification Form developed by the researcher by making use of the trans-theoretical model and adapting it to diabetic patients.The discussions were completed in four weeks, with one discussion held every week. The final test and the Diabetes Self-Management Instrument were applied again to the members of the intervention group in the third month after completion of the MI method sessions and in the third month to the control group.
3 months
Secondary Outcomes (1)
Comparison of the pretest-posttest HbA1c values
3 months
Study Arms (2)
Experimental group
EXPERIMENTALAfter the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions of 30-60 (mean 45 min) min each. The sessions were structured according to the Behavior Change Stage Identification Form developed by the researcher by making use of the trans-theoretical model and adapting it to diabetic patients. The subject of the first session was "Opening, Structuring the Discussion, and Establishing the Agenda"; the subject of the second session was "Improving Motivation for Change"; the subject of the third session was "Summarizing, Support, and Talking about the Change"; and the subject of the fourth session was "Evaluation" . The discussions were completed in four weeks, with one discussion held every week. The final test and the Diabetes Self-Management Instrument were applied again to the members of the intervention group in the third month after completion of the MI method sessions.
Control group
NO INTERVENTIONThe control group received routine treatment. The final test and the Diabetes Self-Management Instrument were applied again to the members of the control group in the third month.
Interventions
After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions.The pretest and posttest Diabetes Self-Management Scale total scores and HbA1c values of the patients in the experimental and control groups were compared.
Eligibility Criteria
You may qualify if:
- years and older
- Having been diagnosed with type 2 diabetes for more than 3 months
- Being in the contemplation
- Preparation, and/or action stages of any section of the Behavioral Change Stage Identification Form of the Trans-Theoretical Model
- Having HbA1c levels above 6
- Agreeing to take part in the study
You may not qualify if:
- Having a perception disorder that will prevent communication
- Having been diagnosed with any mental disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ministry of Health, Gaziosmanpasa Training and Research Hospital
Istanbul, 34255, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deniz Kaya Meral, Phd
Ministry of Health, Gaziosmanpasa Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Without knowing that participants are in the experimental or control group
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 8, 2021
First Posted
January 12, 2022
Study Start
February 7, 2017
Primary Completion
May 7, 2017
Study Completion
December 7, 2017
Last Updated
January 12, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share to Individual participant data